Systemic immune-inflammation index is a promising noninvasive marker to predict survival of lung cancer: A meta-analysis

BACKGROUND: The prognostic value of pretreatment systemic immune-inflammation index (SII) in lung cancer has yet to be fully established. METHODS: Relevant articles were obtained by performing a systematic search. Hazard ratios (HRs) and 95% confidence intervals (95% CIs) were used to assess the rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yi, Chen, Bo, Wang, Lijuan, Wang, Rong, Yang, Xianjin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370019/
https://www.ncbi.nlm.nih.gov/pubmed/30653090
http://dx.doi.org/10.1097/MD.0000000000013788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370019/
https://www.ncbi.nlm.nih.gov/pubmed/30653090
http://dx.doi.org/10.1097/MD.0000000000013788

Ejemplares similares